Medicine and Dentistry
Neuromelanin
100%
Transcranial Direct Current Stimulation
100%
Substantia nigra
100%
Parkinson's Disease
100%
Magnetic Resonance Imaging
91%
Myelin Oligodendrocyte Glycoprotein
83%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
66%
Diseases
66%
Sudden Unexpected Death in Epilepsy
50%
Polyarteritis nodosa
50%
Subarachnoid Hemorrhage
50%
Spectrum Disorder
50%
Optic Neuritis
50%
Prevalence
50%
Forensic Autopsy
50%
Tauopathy
50%
Multiple Sclerosis
50%
Headache
50%
Encephalitis
50%
Migraine Aura
50%
Lomerizine
50%
Disease
45%
Cerebral Cortex
33%
Pulse Rate
33%
Pseudoaneurysm
30%
Single-Photon Emission Computed Tomography
25%
Stereotypic Movement Disorder
25%
Arteritis
20%
Artery
20%
Optic Nerve
16%
Visual Impairment
16%
Blood Examination
16%
Gadolinium
16%
Plasma Exchange
16%
Occipital Lobe
16%
Prednisolone
16%
Dysarthria
16%
Tinnitus
16%
Middle Cerebral Artery
16%
Nausea
16%
Blood Flow
16%
Early Diagnosis
16%
Leptomeninx
16%
Early Intervention
16%
Accidental Death
16%
Genetic Analysis
16%
Electrical Brain Stimulation
12%
Hand Function
12%
Repetitive Transcranial Magnetic Stimulation
12%
Decarboxylase Inhibitor
12%
Keyphrases
Neuromelanin
100%
Transcranial Direct-current Stimulation (tDCS)
100%
Parkinson Patients
100%
Substantia Nigra
100%
Polar Areas
66%
Polyarteritis Nodosa
50%
Neuromelanin-sensitive MRI
50%
Subarachnoid Hemorrhage
50%
Sudden Death
50%
Tumefactive Demyelinating Lesion
50%
Bilateral Optic Neuritis
50%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
50%
Autopsy Study
50%
Forensic Autopsy
50%
Primary Age-related tauopathy
50%
Older Adults
50%
Myelin Oligodendrocyte Glycoprotein Antibody
50%
Cortical Encephalitis
50%
Lomerizine
50%
Visual Symptoms
50%
Migraine without Aura (MWoA)
50%
Neuronal Intranuclear Inclusion Disease
50%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
37%
Parkinson's Disease
33%
Single-photon Emission Computed Tomography (SPECT)
33%
Pseudoaneurysm
30%
Multiple Sclerosis
25%
Movement Disorder Society
16%
Dopa Decarboxylase
16%
SNpc
16%
Minimal Clinically Important Difference
16%
Diffusion Tensor Imaging DTI
16%
Substantia Nigra Pars Compacta
16%
Repetitive Transcranial Magnetic Stimulation (rTMS)
16%
Clinically Meaningful Improvement
16%
Timed Up-and-go Test
16%
Monoamine Oxidase B (MAO-B)
16%
Dopamine Transporter
16%
Arterial Spin Labeling
16%
Decarboxylase
16%
PFC Prefrontal Cortex
16%
Hand Function
16%
Simple Test
16%
Dopaminergic Neurons
16%
Primary Motor Cortex
16%
Non-invasive Brain Stimulation
16%
Trail Making Test
16%
Magnetic Resonance Imaging
16%
Locus Coeruleus
16%
Motor Impairment
16%
Neuroscience
Neuromelanin
100%
Parkinson's Disease
100%
Substantia nigra
100%
Transcranial Direct Current Stimulation
100%
Myelin Oligodendrocyte Glycoprotein
100%
Magnetic Resonance Imaging
62%
Optic Neuritis
50%
Tauopathy
50%
Polyneuropathy
50%
Adenosine Triphosphate
50%
Encephalitis
50%
Auras
50%
Migraine
50%
Multiple Sclerosis
37%
Spectrum Disorder
37%
Headache
37%
Magnetic Resonance Imaging
25%
Transcranial Magnetic Stimulation
25%
Stereotypic Movement Disorder
25%
Single-Photon Emission Computed Tomography
25%
Cerebral Cortex
25%
Iodine-123
12%
Iobenguane
12%
Occipital Lobe
12%
Prednisolone
12%
Optic Nerve
12%
Substantia Nigra Pars Compacta
12%
Monoamine Oxidase B
12%
Carboxy-Lyases
12%
Dopamine Transporter
12%
Ventral Tegmental Area
12%
Aromatic L-Amino Acid Decarboxylase Inhibitor
12%
Arterial Spin Labeling
12%
Diffusion Tensor Imaging
12%
Primary Motor Cortex
12%
Electrical Brain Stimulation
12%
Dopaminergic Neuron
12%
Locus Coeruleus
12%
Blood Plasma
12%
Prefrontal Cortex
12%
Tinnitus
12%
Leptomeninx
12%
Dysarthria
12%
Middle Cerebral Artery
12%
Nervous System Disorder
11%